Insider Cluster (2 insiders) ·Filed May 1, 2026
Insider cluster: 2 insiders, $239K total
Actionable Insight • Neutral
Insider selling is minimal and not indicative of negative outlook. No trading action warranted based on this cluster alone.
ARQT drugs
ARQT drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60Entry
$23.35
T+0 close · Apr 30, 2026 · via day close
Latest settled
+21.71%
T+60 · $28.42
Vs SPY
+18.64%
α at T+60
Horizons
All settled
through T+60
- T+0 · May 1 $23.35entry
- T+1 · 7mo ago +0.60%α +0.94% · $23.49
- T+5 · 6mo ago −11.52%α −13.87% · $20.66
- T+20 · 6mo ago −8.05%α −13.34% · $21.47
- T+60 · 4mo ago +21.71%α +18.64% · $28.42
Price Chart
REPLAYWatch the reaction play outLoading chart...
How similar events traded
Executive Summary
Two insiders sold a total of $239K in ARQT shares, representing only 0.008% of market cap. This is trivial and routine activity with no material signal.
Key Financial Metrics
Direction
selling
Total Value
$239.0K
Insiders
2
Key Facts
- Director Howard G. Welgus sold 7,144 shares ($164K) on 2026-05-01
- Todd Watanabe (See Remarks) sold 3,172 shares ($75K) on 2026-05-04
- Total insider sales of $239K are 0.008% of ARQT's $2.9B market cap
- No insider purchases were made in the cluster period
Financial Impact
Insider sales of $239K are negligible relative to market cap
insider holdings
Risk Factors
- Insider selling could increase in future periods, but current activity is trivial
- No identifiable catalyst from the filings provided
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (14 analysts)
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-ARQT-1778105196590 |
Track record
34 reports on ARQT
3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +21.34% at T+60 after the Aug 5, 2026 report. 4 of 4 went positive at some point.
Filters
- Nov 13, 20263d ago Press Release Neutral 4/10 Entry $28.26 Now $27.15 −3.93% settles Feb 11
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $27.39 Now $27.15 −0.86% settles Feb 8
- Nov 6, 202610d ago Institutional Cluster Neutral 3/10 Entry $25.55 Now $27.15 +6.26% settles Feb 4
- Nov 4, 202612d ago 3/A / CLUSTER / 3 Neutral 2/10 Entry $27.00 Now $27.15 +0.56% settles Feb 3
- Nov 4, 202612d ago 144 Neutral 3/10 Entry $27.00 Now $27.15 +0.56% settles Feb 3
- Nov 4, 202612d ago 424B5 Bearish 4/10 Entry $27.00 Now $27.15 −0.56% settles Feb 3
- Nov 4, 202612d ago 8-K Neutral 5/10 No price data
- Nov 4, 202612d ago Press Release Mixed 6/10 Entry $27.00 Now $27.15 +0.56% settles Feb 3
- Nov 2, 202614d ago 144 Neutral 2/10 Entry $32.00 Now $27.15 −15.16% settles Feb 1
- Nov 2, 202614d ago 144 Neutral 2/10 Entry $32.00 Now $27.15 −15.16% settles Feb 1
Showing 10 of 34
US Market Status
Market Closed · Opens Wed (10h 45m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers